Survival after recurrence following surgical resected non-small cell lung cancer: A multicenter, prospective cohort study.

ABSTRACT:

Objectives

The optimal treatment for recurrent non-small cell lung cancer (NSCLC) has not been standardized. In this prospective cohort study, we evaluated post-recurrence survival (PRS) after treatment of recurrent NSCLC and identified prognostic factors after recurrence.

Methods

This multicenter prospective cohort study was conducted in 14 hospitals. The inclusion criteria for this study were patients with recurrence after radical resection for NSCLC. Information about the patient characteristics at recurrence, tumor-related variables, primary surgery, and treatment for recurrence was collected. After registration, follow-up data, such as treatment and survival outcomes, were obtained every 3 months.

Results

From 2010 to 2015, 505 cases were enrolled, and 495 cases

SUBMITTER: Takenaka T 

PROVIDER: S-EPMC9390543 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature